Risk factors for serious adverse events related to vitamin K antagonists in children with congenital or acquired heart disease: a prospective cohort study

To assess the occurrence of thrombosis and major bleeding in children with congenital or acquired heart disease (CAHD) treated with VKA and to identify risk factors for these serious adverse events (SAE).

Source: Thrombosis Research - November 7, 2023 Category: Hematology Authors: Fanny Bajolle, Neil Derridj, Joan Bitan, Aurelie Grazioli, Nicolas Pallet, Dominique Lasne, Damien Bonnet Source Type: research